A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.

A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas. — المؤلف: Trucco, Matteo M — Clinical sarcoma research 2018

المؤلف
Trucco, Matteo M
النشر
Clinical sarcoma research 2018
الوصف
21 p.